Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

25 Jul 2017 07:00

RNS Number : 9826L
Compagnie de Saint-Gobain
25 July 2017
 

PRESS RELEASE

 

July 25, 2017

 

Saint-Gobain acquires TekBond,

adhesives specialist in Brazil

 

 

 

Saint-Gobain has signed a share purchase agreement to acquire 100% of the equity capital of TekBond, the number two adhesives business in Brazil operating in the construction sector and on the automotive aftermarket.

 

TekBond supplies a broad range of adhesives, sealants, sprays and masking tapes all over Brazil. Its offer is based on a detailed knowledge of the market and customers to adjust its product formulations to local specificities.

 

TekBond will join the High-Performance Materials Activity. This acquisition will enable Saint-Gobain in Brazil to create important synergies with the Abrasives, Mortars and Flat Glass business lines on the construction and industrial markets.

 

The deal is subject to the approval of the Brazilian antitrust authorities.

 

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€39.1 billion in sales in 2016

Operates in 67 countries

More than 170,000 employees

www.saint-gobain.com @saintgobain

 

 

Analyst/Investor relations

 

 

Media relations

Vivien Dardel

Florent Nouveau

Floriana Michalowska

 +33 1 47 62 44 29

 +33 1 47 62 30 93

 +33 1 47 62 35 98

 

Susanne Trabitzsch

 

 +33 1 47 62 43 25

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRAMATMBATMFR
Date   Source Headline
14th Apr 20207:12 amRNSCo-optation of a director
30th Mar 20207:07 amRNSIssue of Debt
23rd Mar 20207:34 amRNSCoronavirus pandemic update
10th Mar 20207:06 amRNSDisposal
28th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 20204:59 pmRNSFull-Year Results 2019
30th Jan 20207:02 amRNSAcquisition
24th Jan 20207:00 amRNSResolution of asbestos liabilities
21st Jan 20207:06 amRNSCDP Climate change A List
7th Jan 20205:07 pmRNSAcquisition
7th Jan 20207:07 amRNSAcquisition
6th Jan 20205:05 pmRNSDisposal
20th Dec 20197:08 amRNSDisposal
2nd Dec 20197:35 amRNSSaint-Gobain completes the divestment of DMTP
29th Nov 20195:15 pmRNSNew production line
29th Nov 20197:07 amRNSCancelation of shares
13th Nov 20197:00 amRNSAcquisition
4th Nov 20195:08 pmRNSDisposal
4th Nov 20197:04 amRNSDisposal
25th Oct 201912:18 pmRNS3rd Quarter Results
16th Oct 20197:07 amRNSAcquisition
7th Oct 20195:16 pmRNSDisposal
1st Oct 20195:07 pmRNSDisposal
30th Sep 20195:39 pmRNSDisposal
30th Sep 20197:21 amRNSDisposal
23rd Sep 20195:08 pmRNSCommitment
12th Sep 20196:15 pmRNSAmended Final Terms
26th Jul 20197:00 amRNSHalf-year Report
18th Jul 20195:16 pmRNSDisposal
1st Jul 20197:07 amRNSAccounting standards
19th Jun 20197:54 amRNSDisposal
14th Jun 20195:02 pmRNSCancellation of shares
7th Jun 20197:00 amRNSAGM Statement
28th May 20196:11 pmRNSAcquisition
20th May 20197:48 amRNSDisposal
14th May 20195:44 pmRNSFinal Terms
14th May 20195:16 pmRNSDisposal
2nd May 20195:32 pmRNSFinal Terms
25th Apr 20194:59 pmRNS1st Quarter Results
24th Apr 20197:08 amRNSAcquisition
8th Apr 20199:29 amRNSFinal Terms
25th Mar 20195:38 pmRNSFinal Terms
22nd Mar 20193:50 pmRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
7th Mar 201910:24 amRNSStabilisation Notice
6th Mar 20195:34 pmRNSIssue of Debt
6th Mar 20199:01 amRNSStabilisation Notice
5th Mar 20195:42 pmRNSProspectus Supplement
21st Feb 20195:13 pmRNSAnnual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.